Malioxamycin, with the CAS number 73020-27-6, is a chemical compound that belongs to the class of antibiotics known as macrolides. It is characterized by its complex structure, which typically includes a large lactone ring and various functional groups that contribute to its biological activity. Malioxamycin exhibits antimicrobial properties, making it effective against a range of bacterial infections. Its mechanism of action generally involves inhibiting protein synthesis in bacteria, thereby preventing their growth and replication. The compound is often studied for its potential therapeutic applications, particularly in the treatment of resistant bacterial strains. Additionally, malioxamycin may possess unique pharmacokinetic properties, influencing its absorption, distribution, metabolism, and excretion in biological systems. Research into malioxamycin continues to explore its efficacy, safety, and potential side effects, as well as its role in the development of new antibiotic therapies. As with many antibiotics, the emergence of resistance is a critical concern, necessitating ongoing studies to optimize its use in clinical settings.

Malioxamycin is an antibiotic with spheroplast-forming activity. It is formed from a valine and amino group attached to a malic acid moiety.

malioxamycin

73020-27-6: Malioxamycin, with the CAS number 73020-27-6, is a chemical compound that belongs to the class of antibiotics known as macrolides. It is characterized by its complex structure, which typically includes a large lactone ring and various functional groups that contribute to its biological activity. Malioxamycin exhibits antimicrobial properties, making it effective against a range of bacterial infections. Its mechanism of action generally involves inhibiting protein synthesis in bacteria, thereby preventing their growth and replication. The compound is often studied for its potential therapeutic applications, particularly in the treatment of resistant bacterial strains. Additionally, malioxamycin may possess unique pharmacokinetic properties, influencing its absorption, distribution, metabolism, and excretion in biological systems. Research into malioxamycin continues to explore its efficacy, safety, and potential side effects, as well as its role in the development of new antibiotic therapies. As with many antibiotics, the emergence of resistance is a critical concern, necessitating ongoing studies to optimize its use in clinical settings.

<p>Malioxamycin is an antibiotic that inhibits Gram-negative bacteria by suppressing peptidoglycan synthesis in the bacterial cell wall and promoting the formation of protoplasts.</p>

CAS 73020-27-6

malioxamycin

Malioxamycin

Ref: TM-TN10484